Brown Miller Wealth Management LLC lifted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 4.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,823 shares of the company’s stock after acquiring an additional 714 shares during the quarter. Brown Miller Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $483,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Envestnet Portfolio Solutions Inc. acquired a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $274,000. Hilltop Holdings Inc. boosted its holdings in ARK Genomic Revolution ETF by 6.0% during the fourth quarter. Hilltop Holdings Inc. now owns 7,652 shares of the company’s stock worth $251,000 after buying an additional 433 shares in the last quarter. Principal Securities Inc. bought a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $32,000. Goldman Sachs Group Inc. boosted its holdings in ARK Genomic Revolution ETF by 271.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock worth $21,090,000 after buying an additional 469,740 shares in the last quarter. Finally, BKM Wealth Management LLC bought a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $78,000.
ARK Genomic Revolution ETF Stock Performance
BATS:ARKG traded down $0.25 during trading hours on Friday, reaching $23.48. 2,943,563 shares of the company’s stock were exchanged. The stock has a 50 day moving average price of $25.00 and a 200-day moving average price of $28.09.
ARK Genomic Revolution ETF Company Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Read More
- Five stocks we like better than ARK Genomic Revolution ETF
- Earnings Per Share Calculator: How to Calculate EPS
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 6/24 – 6/28
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
